PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Ultra-LEAF™ Purified anti-mouse IFNAR-1, 25 mg
Ultra-LEAF™ Purified anti-mouse IFNAR-1, 5 mg
Ultra-LEAF™ Purified anti-mouse IL-33Rα (ST2), 500 μg
Ultra-LEAF™ Purified anti-mouse Ly-6G, 1 mg
Ultra-LEAF™ Purified anti-mouse Ly-6G, 25 mg
Ultra-LEAF™ Purified anti-mouse Ly-6G, 5 mg
Ultra-LEAF™ Purified anti-mouse Ly-6G/Ly-6C (Gr-1), 1 mg
Ultra-LEAF™ Purified anti-mouse Ly-6G/Ly-6C (Gr-1), 100 μg
Ultra-LEAF™ Purified anti-mouse Ly-6G/Ly-6C (Gr-1), 25 mg
Ultra-LEAF™ Purified anti-mouse Ly-6G/Ly-6C (Gr-1), 5 mg
Ultra-LEAF™ Purified anti-mouse/human CD11b, 1 mg
Ultra-LEAF™ Purified anti-mouse/human CD282 (TLR2) Recombinant, 1 mg
Ultra-LEAF™ Purified anti-mouse/human CD282 (TLR2) Recombinant, 100 μg
Ultra-LEAF™ Purified anti-mouse/human CD44, 1 mg
Ultra-LEAF™ Purified anti-mouse/human LAP (TGF-β1), 1 mg
Ultra-LEAF™ Purified anti-mouse/human LAP (TGF-β1), 100 μg